Dr. Janine Ladislaw’s practice focuses on strategic IP counseling, including preparing and prosecuting patent applications, developing strategy for patent prosecution, performing patentability and freedom-to-operate analyses, and providing clients with due diligence assessments of patent portfolios in connection with technology transactions and acquisitions. She has obtained numerous domestic and foreign patents for emerging companies, public corporations, universities, and independent research institutions in a wide range of technical areas, including the fields of polymer chemistry, materials science, pharmaceuticals, small molecule drug discovery, synthetic methods, clean technology, biochemistry, and laboratory equipment and devices. Janine has been the lead chemist on the patent portfolio relating to a small molecule kinase inhibitor that is FDA-approved for the treatment of various leukemias and lymphomas; the drug has a projected annual net revenue of $5 billion by 2020.More »
Industries:Energy & Climate Education Life Sciences Technology
- Boston College Law School, J.D.
- University of Pennsylvania, Ph.D. in Organic and Polymer Chemistry
- College of William and Mary, B.S. in Chemistry, cum laude